PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

This project is part of the EDCTP2 Programme supported by the European Union.
EDCTP
EU

Search

Search

  • About us
    • What we do
    • Governance
    • PAMAfrica scientists
    • PAMAfrica students
  • Work packages
    • Next-generation drug combination for uncomplicated malaria
    • First malaria treatment for babies under 5kg
    • New medicine for treatement of severe malaria
    • Building research capacity
  • Consortium partners
  • Newsroom
    • Resources
    • News
Search
HomeAbout usPAMAfrica scientists

PAMAfrica scientists

1

Dr Yeka Adoke

Ph.D, Director and Principal Investigator at IDRC (WP 1)

Miss Sarita Barsainya

Masters in Pharmacy, Global Trial Director at Novartis (WP 3)

Dr Quique Bassat

PhD, Head of the Malaria Programme at ISGlobal (WP 2)

Dr Helen Demarest

PhD, Director, Clinical Operations for MMV (WP 4)

Dr Ghyslain Mombo-Ngoma

MD, PhD, Head of Clinical Operations at CERMEL (WP 1 - WP 3)

Dr Alphonse Ouédraogo

MD, PhD, Senior Field Coordinator at GRAS (WP 1 - WP 3)

Dr Celine Risterucci

PhD, Global Clinical Development Director at Novartis (WP 2)

Dr Alfred Tiono

MD, PhD, Associate Researcher at GRAS (WP 1 - WP 3)

Dr Rella Zoleko Manego

MD,MPH, Clinical Researcher at CERMEL (WP 1 - WP 3)

Contact us

infopamafrica [at] mmv [dot] org

A Remora website by Manta Ray Media